Suppressed levels of growth hormone and insulin-like growth factor-1 during successful pregnancy in persistent acromegaly

被引:10
|
作者
Shimatsu, Akira [1 ]
Usui, Takeshi
Tagami, Tetsuya
Kuzuya, Hideshi
Takahashi, Jun A. [2 ]
机构
[1] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Fushimi Ku, Kyoto 6128555, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068907, Japan
关键词
Acromegaly; Pregnancy; IGF-1; Octreotide; Radiosurgery; SMS-201-995; WOMEN; WOMAN;
D O I
10.1507/endocrj.K10E-069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pregnancy is a rather rare event in acromegaly because fertility is often reduced during active disease. Previous reports of pregnancy in acromegalic patients showed that the pituitary growth hormone (OH) level was unaffected and the insulin-like growth factor (IGF)-1 level was elevated during the second and third trimesters. We describe here a case of persistent acromegaly that showed suppressed levels of OH and IGF-1 during pregnancy. The suppression of OH secretion and IGF-1 may be due to increased estrogen or other factors circulating in mid- to late pregnancy.
引用
收藏
页码:551 / 553
页数:3
相关论文
共 50 条
  • [1] Insulin-like growth factor-1, growth hormone and disease outcomes in acromegaly: A population study
    Thomas, Melissa
    Berni, Ellen
    Jenkins-Jones, Sara
    Wensley, Sarah
    Poole, Chris D.
    Currie, Craig J.
    Brownrigg, Jack
    Ayuk, John
    Rees, D. Aled
    CLINICAL ENDOCRINOLOGY, 2021, 95 (01) : 143 - 152
  • [2] Growth hormone, insulin-like growth factor-1 and the aging brain
    Ashpole, Nicole M.
    Sanders, Jessica E.
    Hodges, Erik L.
    Yan, Han
    Sonntag, William E.
    EXPERIMENTAL GERONTOLOGY, 2015, 68 : 76 - 81
  • [3] The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery
    Wu, Tzu-En
    Lin, Hong-Da
    Lu, Ron-A
    Wang, Mei-Li
    Chen, Ru-Lin
    Chen, Harn-Shen
    GROWTH HORMONE & IGF RESEARCH, 2010, 20 (06) : 411 - 415
  • [4] Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management
    Mehdi Zeinalizadeh
    Zohreh Habibi
    Juan C. Fernandez-Miranda
    Paul A. Gardner
    Steven P. Hodak
    Sue M. Challinor
    Pituitary, 2015, 18 : 48 - 59
  • [5] Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management
    Zeinalizadeh, Mehdi
    Habibi, Zohreh
    Fernandez-Miranda, Juan C.
    Gardner, Paul A.
    Hodak, Steven P.
    Challinor, Sue M.
    PITUITARY, 2015, 18 (01) : 48 - 59
  • [6] The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin
    Nijenhuis-Noort, Eline C.
    Berk, Kirsten A.
    Neggers, Sebastian J. C. M. M.
    van der Lely, Aart J.
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 83 - 89
  • [7] Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: A case report
    Wijayaratne D.R.
    Arambewela M.H.
    Dalugama C.
    Wijesundera D.
    Somasundaram N.
    Katulanda P.
    Journal of Medical Case Reports, 9 (1)
  • [8] Elevated insulin-like growth factor-1 in patients without clinical evidence of acromegaly
    Careless, Laura
    Inder, Warrick J.
    Pretorius, Carel
    Hayes, Lisa
    CLINICAL ENDOCRINOLOGY, 2023, 99 (03) : 296 - 305
  • [9] Role of ghrelin on growth hormone/insulin-like growth factor-1 axis during endotoxemia
    Faim, Felipe
    Passaglia, Patricia
    Batalhao, Marcelo
    Lacchini, Riccardo
    Stabile, Angelita Maria
    Carnio, Evelin Capellari
    GROWTH HORMONE & IGF RESEARCH, 2019, 48-49 : 36 - 44
  • [10] The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly
    Bastemir, Mehmet
    Akin, Fulya
    Yaylali, Guzin Fidan
    NEUROENDOCRINOLOGY, 2007, 86 (02) : 119 - 123